British researchers have taken a key step in developing a single blood test for a range of cancers, it has been announced.
Research in recent years has identified some 788 biomarkers that could be used for screening, according to the Sheffield University researchers who have listed all the substances.
They say it is likely a test will be developed using 50 biomarkers.
The list was compiled from more than 19,000 scientific studies reported over the last five years.
The project has been backed by Cancer Research UK and commissioned by the Early Cancer Detection Consortium. It hopes the first tests will be available within three years for high risk patients.
Researcher Dr Lesley Uttley said: "Because of the sheer number of publications in this field, previous reviews have only been able to look at one biomarker or a small group of biomarkers.
"Our data mining approach allowed us to take in all relevant research findings from the five-year period, which meant we could map the full range of potential blood-based biomarkers that are particularly relevant for early detection of cancer."
Consortium director Professor Ian Cree, of University Hospitals Coventry and Warwickshire NHS Trust, said: "Our expectation is that, once the validation and clinical studies are completed, we will have a suite of around 50 biomarkers, identified using four different tests, that can go into the clinical trial.
"To complete the validation and the trials will take six to eight years, but in theory, we could have a test ready within three years for use in high risk groups.
"Our vision is that the screen will pick up even the small amounts of these biomarkers that might be in the blood at an early stage of the cancer, without necessarily identifying which cancer they relate to. Patients would then be referred for more specific tests, that could narrow down the tumour type."

Leave a Reply